Neil F. McFarlane - May 16, 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
Director
Signature
/s/ Shirley R. Kuhlmann as Attorney-in-Fact for Neil F. McFarlane
Stock symbol
COLL
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/16/2024, 07:23 PM
Previous filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +7.69K +18.46% $0.00 49.4K May 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.